ROYAL BRISBANE AND WOMEN'S HOSPITAL
🇦🇺Australia
- Country
- 🇦🇺Australia
- Ownership
- -
- Established
- 2003-01-01
- Employees
- -
- Market Cap
- -
Clinical Trials
72
Active:3
Completed:25
Trial Phases
5 Phases
Phase 1:5
Phase 2:5
Phase 3:3
+2 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (61 trials with phase data)• Click on a phase to view related trials
Not Applicable
40 (65.6%)Phase 4
8 (13.1%)Phase 1
5 (8.2%)Phase 2
5 (8.2%)Phase 3
3 (4.9%)Pharmacokinetics of Ceftolozane/Tazobactam in Plasma and Cerebrospinal Fluid
- First Posted Date
- 2017-10-13
- Last Posted Date
- 2020-09-10
- Lead Sponsor
- Royal Brisbane and Women's Hospital
- Target Recruit Count
- 10
- Registration Number
- NCT03309657
- Locations
- 🇦🇺
Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia
Single Dose Population Pharmacokinetics of Intravenous Posaconazole in Critically Ill Patients
- First Posted Date
- 2016-11-18
- Last Posted Date
- 2018-09-21
- Lead Sponsor
- Royal Brisbane and Women's Hospital
- Target Recruit Count
- 8
- Registration Number
- NCT02968134
An Observational Pharmacokinetic Sudy of Ceftolozane-Tazobactam in Intensive Care Unit in Patients With and Without CRRT
Completed
- Conditions
- Gram-Negative Bacterial Infections
- First Posted Date
- 2016-11-15
- Last Posted Date
- 2019-10-02
- Lead Sponsor
- Royal Brisbane and Women's Hospital
- Target Recruit Count
- 18
- Registration Number
- NCT02962934
- Locations
- 🇦🇺
Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia
Breath Testing in Early and Late Larynx Cancer
Completed
- Conditions
- Larynx Cancer
- First Posted Date
- 2012-10-04
- Last Posted Date
- 2017-09-12
- Lead Sponsor
- Royal Brisbane and Women's Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT01700647
- Locations
- 🇦🇺
Royal Brisbane and Womens Hospital, Brisbane, Queensland, Australia
The Clinical Role of Intravenous Glutamine in Trauma Patients Receiving Enteral Nutrition
Phase 3
- Conditions
- Multiple TraumaCritically Ill
- First Posted Date
- 2010-11-15
- Last Posted Date
- 2012-05-24
- Lead Sponsor
- Royal Brisbane and Women's Hospital
- Target Recruit Count
- 88
- Registration Number
- NCT01240291
- Locations
- 🇦🇺
Royal Brisbane & Women's Hospital, Brisbane, Queensland, Australia
- Prev
- 1
- 2
- Next
News
Australian-First "Seek-and-Destroy" Cancer Therapy Begins Human Trials Targeting CDCP1 Protein
A groundbreaking radioactive therapy targeting the CDCP1 protein in cancer cells has begun its first human trial in Australia, with a 69-year-old Brisbane woman becoming the first patient to receive the treatment.